Using designer receptors exclusively activated by designer drugs (DREADD), we showed that chemogenetic orexin neuron activation increases SPA and NEAT, and prevents obesity in mice given a high‐fat diet (C. M. Kotz et al., 2017; Zink et al., 2018). Here, HCRT is linked to obesity due to melanocortin 4 receptor deficiency.